Home Medicine The impact of physiological variations on personalized reference intervals and decision limits: an in-depth analysis
Article
Licensed
Unlicensed Requires Authentication

The impact of physiological variations on personalized reference intervals and decision limits: an in-depth analysis

  • Abdurrahman Coskun ORCID logo EMAIL logo and Giuseppe Lippi ORCID logo
Published/Copyright: March 11, 2024

Abstract

The interpretation of laboratory data is a comparative procedure. Physicians typically need reference values to compare patients’ laboratory data for clinical decisions. Therefore, establishing reliable reference data is essential for accurate diagnosis and patient monitoring. Human metabolism is a dynamic process. Various types of systematic and random fluctuations in the concentration/activity of biomolecules are observed in response to internal and external factors. In the human body, several biomolecules are under the influence of physiological rhythms and are therefore subject to ultradian, circadian and infradian fluctuations. In addition, most biomolecules are also characterized by random biological variations, which are referred to as biological fluctuations between subjects and within subjects/individuals. In routine practice, reference intervals based on population data are used, which by nature are not designed to capture physiological rhythms and random biological variations. To ensure safe and appropriate interpretation of patient laboratory data, reference intervals should be personalized and estimated using individual data in accordance with systematic and random variations. In this opinion paper, we outline (i) the main variations that contribute to the generation of personalized reference intervals (prRIs), (ii) the theoretical background of prRIs and (iii) propose new methods on how to harmonize prRIs with the systematic and random variations observed in metabolic activity, based on individuals’ demography.


Corresponding author: Abdurrahman Coskun, Department of Medical Biochemistry, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Kayisdagi cad., No: 32, 34752 Atasehir, Istanbul, Türkiye, Phone: +90 216 5004960, E-mail:

Acknowledgments

The English of some sentences in this manuscript was polished by ChatGPT. A modified version of Figures 1 and 2 were presented in “AACB 60th Annual Scientific Conference” and “Turkish Biochemical Society, 34th National Biochemistry Congress”.

  1. Research ethics: Not applicable.

  2. Informed consent: Not applicable.

  3. Author contributions: The authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Competing interests: The authors state no conflict of interest.

  5. Research funding: None declared.

  6. Data availability: Not applicable.

References

1. Coskun, A, Zarepour, A, Zarrabi, A. Physiological rhythms and biological variation of biomolecules: the road to personalized laboratory medicine. Int J Mol Sci 2023;24:6275. https://doi.org/10.3390/ijms24076275.Search in Google Scholar PubMed PubMed Central

2. Coskun, A, Lippi, G. Personalized laboratory medicine in the digital health era: recent developments and future challenges. Clin Chem Lab Med 2024;62:402–9. https://doi.org/10.1515/cclm-2023-0808.Search in Google Scholar PubMed

3. Grasbeck, R, Saris, NE. Establishment and use of normal values. Scand J Clin Lab Invest 1969;110:62–3.Search in Google Scholar

4. Gräsbeck, R, Fellman, J. Normal values and statistics. Scand J Clin Lab Invest 1968;21:193–5. https://doi.org/10.3109/00365516809076984.Search in Google Scholar PubMed

5. Siest, G, Henny, J, Gräsbeck, R, Wilding, P, Petitclerc, C, Queraltó, JM, et al.. The theory of reference values: an unfinished symphony. Clin Chem Lab Med 2013;51:47–64. https://doi.org/10.1515/cclm-2012-0682.Search in Google Scholar PubMed

6. Clinical Laboratory Standard Institute (CLSI). Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline. CLSI document EP28-A3c, 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.Search in Google Scholar

7. Daan, S, Aschoff, J. Short-term rhythms in activity. In: Aschoff, J, editor. Biological rhythms. New York, NY, USA: Plenum Press; 1981:491–8 pp.10.1007/978-1-4615-6552-9_25Search in Google Scholar

8. Goh, GH, Maloney, SK, Mark, PJ, Blache, D. Episodic ultradian events-ultradian rhythms. Biology 2019;8:15. https://doi.org/10.3390/biology8010015.Search in Google Scholar PubMed PubMed Central

9. Moser, M, Penter, R, Fruehwirth, M, Kenner, T. Why life oscillates – biological rhythms and health. Conf Proc IEEE Eng Med Biol Soc 2006;2006:424–8. https://doi.org/10.1109/IEMBS.2006.259562.Search in Google Scholar PubMed

10. Bonelli, P, Buonocore, R, Aloe, R, Lippi, G. Blood sampling seasonality as an important preanalytical factor for assessment of vitamin D status. J Med Biochem 2016;35:113–7. https://doi.org/10.1515/jomb-2015-0014.Search in Google Scholar PubMed PubMed Central

11. Hahn, GJ, Meeker, WQ, Escobar, LA. Statistical intervals: a guide for practitioners and researchers. Hoboken, New Jersey: John Wiley & Sons; 2016:651 p.10.1002/9781118594841Search in Google Scholar

12. Coskun, A, Sandberg, S, Unsal, I, Yavuz, FG, Cavusoglu, C, Serteser, M, et al.. Personalized reference intervals – statistical approaches and considerations. Clin Chem Lab Med 2021;60:629–35. https://doi.org/10.1515/cclm-2021-1066.Search in Google Scholar PubMed

13. Hamilton, JD. Time series analysis, 1st ed Princeton, New Jersey: Princeton University Press; 1994.Search in Google Scholar

14. Coskun, A, Sandberg, S, Unsal, I, Serteser, M, Aarsand, AK. Personalized reference intervals: from theory to practice. Crit Rev Clin Lab Sci 2022;59:501–16. https://doi.org/10.1080/10408363.2022.2070905.Search in Google Scholar PubMed

15. Coşkun, A, Sandberg, S, Unsal, I, Cavusoglu, C, Serteser, M, Kilercik, M, et al.. Personalized and population-based reference intervals for 48 common clinical chemistry and hematology measurands: a comparative study. Clin Chem 2023;69:1009–30. https://doi.org/10.1093/clinchem/hvad113.Search in Google Scholar PubMed

16. Carobene, A, Aarsand, AK, Guerra, E, Bartlett, WA, Coşkun, A, Díaz-Garzón, J, et al.. European Biological Variation Study (EuBIVAS): within- and between-subject biological variation data for 15 frequently measured proteins. Clin Chem 2019;65:1031–41. https://doi.org/10.1373/clinchem.2019.304618.Search in Google Scholar PubMed

17. Carobene, A, Guerra, E, Locatelli, M, Cucchiara, V, Briganti, A, Aarsand, AK, et al.. Biological variation estimates for prostate specific antigen from the European Biological Variation Study; consequences for diagnosis and monitoring of prostate cancer. Clin Chim Acta 2018;486:185–91. https://doi.org/10.1016/j.cca.2018.07.043.Search in Google Scholar PubMed

18. Cavalier, E, Lukas, P, Bottani, M, Aarsand, AK, Ceriotti, F, Coşkun, A, et al.. European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates of β-isomerized C-terminal telopeptide of type I collagen (β-CTX), N-terminal propeptide of type I collagen (PINP), osteocalcin, intact fibroblast growth factor 23 and uncarboxylated-unphosphorylated matrix-Gla protein-a cooperation between the EFLM Working group on biological variation and the International Osteoporosis Foundation-International Federation of Clinical Chemistry Committee on Bone Metabolism. Osteoporos Int 2020;31:1461–70. https://doi.org/10.1007/s00198-020-05362-8.Search in Google Scholar PubMed

19. Coşkun, A, Aarsand, AK, Sandberg, S, Guerra, E, Locatelli, M, Díaz-Garzón, J, et al.. Within- and between-subject biological variation data for tumor markers based on the European Biological Variation Study. Clin Chem Lab Med 2021;60:543–52. https://doi.org/10.1515/cclm-2021-0283.Search in Google Scholar PubMed

20. Díaz-Garzón, J, Fernández–Calle, P, Minchinela, J, Aarsand, AK, Bartlett, WA, Aslan, B, et al.. Biological variation data for lipid cardiovascular risk assessment biomarkers. A systematic review applying the biological variation data critical appraisal checklist (BIVAC). Clin Chim Acta 2019;495:467–75. https://doi.org/10.1016/j.cca.2019.05.013.Search in Google Scholar PubMed

21. Aarsand, AK, Røraas, T, Bartlett, WA, Coşkun, A, Carobene, A, Fernandez-Calle, P, et al.. Harmonization initiatives in the generation, reporting and application of biological variation data. Clin Chem Lab Med 2018;56:1629–36. https://doi.org/10.1515/cclm-2018-0058.Search in Google Scholar PubMed

22. González-Lao, E, Corte, Z, Simón, M, Ricós, C, Coskun, A, Braga, F, et al.. Systematic review of the biological variation data for diabetes related analytes. Clin Chim Acta 2019;488:61–7. https://doi.org/10.1016/j.cca.2018.10.031.Search in Google Scholar PubMed

23. Marques-Garcia, F, Boned, B, González-Lao, E, Braga, F, Carobene, A, Coskun, A, et al.. Critical review and meta-analysis of biological variation estimates for tumor markers. Clin Chem Lab Med 2022;60:494–504. https://doi.org/10.1515/cclm-2021-0725.Search in Google Scholar PubMed

24. Aarsand, AK, Fernandez-Calle, P, Webster, C, Coskun, A, Gonzales-Lao, E, Diaz-Garzon, J, et al.. The EFLM biological variation database. https://biologicalvariation.eu/ [Accessed Jan 2024].Search in Google Scholar

25. Zisapel, N. New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. Br J Pharmacol 2018;175:3190–9. https://doi.org/10.1111/bph.14116.Search in Google Scholar PubMed PubMed Central

26. Carobene, A, Guerra, E, Marqués-García, F, Boned, B, Locatelli, M, Coşkun, A, et al.. Biological variation of morning serum cortisol: updated estimates from the European biological variation study (EuBIVAS) and meta-analysis. Clin Chim Acta 2020;509:268–72. https://doi.org/10.1016/j.cca.2020.06.038.Search in Google Scholar PubMed

27. Azmi, NASM, Juliana, N, Azmani, S, Effendy, NM, Abu, IF, Teng, NIMF, et al.. Cortisol on circadian rhythm and its effect on cardiovascular system. Int J Environ Res Public Health 2021;18:1–15.10.3390/ijerph18020676Search in Google Scholar PubMed PubMed Central

28. Orisaka, M, Miyazaki, Y, Shirafuji, A, Tamamura, C, Tsuyoshi, H, Tsang, BK, et al.. The role of pituitary gonadotropins and intraovarian regulators in follicle development: a mini-review. Reprod Med Biol 2021;20:169–75. https://doi.org/10.1002/rmb2.12371.Search in Google Scholar PubMed PubMed Central

29. Min, J, Demchyshyn, S, Sempionatto, JR, Song, Y, Hailegnaw, B, Xu, C, et al.. An autonomous wearable biosensor powered by a perovskite solar cell. Nat Electron 2023;6:630–41. https://doi.org/10.1038/s41928-023-00996-y.Search in Google Scholar PubMed PubMed Central

30. Asgari, S, Higgins, V, McCudden, C, Adeli, K. Continuous reference intervals for 38 biochemical markers in healthy children and adolescents: comparisons to traditionally partitioned reference intervals. Clin Biochem 2019;73:82–9. https://doi.org/10.1016/j.clinbiochem.2019.08.010.Search in Google Scholar PubMed

31. Ammer, T, Schützenmeister, A, Prokosch, H-U, Rauh, M, Rank, CM, Zierk, J. A pipeline for the fully automated estimation of continuous reference intervals using real-world data. Sci Rep 2023;13:13440. https://doi.org/10.1038/s41598-023-40561-3.Search in Google Scholar PubMed PubMed Central

32. Yan, R, Peng, Y, Hu, L, Zhang, W, Li, Q, Wang, Y, et al.. Continuous reference intervals for 21 biochemical and hematological analytes in healthy Chinese children and adolescents: the PRINCE study. Clin Biochem 2022;102:9–18. https://doi.org/10.1016/j.clinbiochem.2022.01.004.Search in Google Scholar PubMed

33. Hall, A, Bohn, MK, Wilson, S, Higgins, V, Adeli, K. Continuous reference intervals for 19 endocrine, fertility, and immunochemical markers in the CALIPER cohort of healthy children and adolescents. Clin Biochem 2021;94:35–41. https://doi.org/10.1016/j.clinbiochem.2021.04.014.Search in Google Scholar PubMed

34. Coskun, A. Bias in laboratory medicine: the dark side of the moon. Ann Lab Med 2024;44:6–20. https://doi.org/10.3343/alm.2024.44.1.6.Search in Google Scholar PubMed PubMed Central

35. Apple, FS, Ler, R, Murakami, MAM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem 2012;58:1574–81. https://doi.org/10.1373/clinchem.2012.192716.Search in Google Scholar PubMed

36. Diaz-Garzon, J, Fernandez-Calle, P, Sandberg, S, Özcürümez, M, Bartlett, WA, Coskun, A, et al.. Biological variation of cardiac troponins in health and disease: a systematic review and meta-analysis. Clin Chem 2021;67:256–64. https://doi.org/10.1093/clinchem/hvaa261.Search in Google Scholar PubMed

37. Ceriotti, F, Marco, JDG, Fernandez-Calle, P, Maregnani, A, Aarsand, AK, Coskun, A, et al.. The European Biological Variation Study (EuBIVAS): weekly biological variation of cardiac troponin I estimated by the use of two different high-sensitivity cardiac troponin I assays. Clin Chem Lab Med 2020;58:1741–7. https://doi.org/10.1515/cclm-2019-1182.Search in Google Scholar PubMed

38. Fournier, S, Iten, L, Marques-Vidal, P, Boulat, O, Bardy, D, Beggah, A, et al.. Circadian rhythm of blood cardiac troponin T concentration. Clin Res Cardiol 2017;106:1026–32. https://doi.org/10.1007/s00392-017-1152-8.Search in Google Scholar PubMed

39. Chaulin, AM, Duplyakov, DV. On the potential effect of circadian rhythms of cardiac troponins on the diagnosis of acute myocardial infarction. Signa Vitae 2021;17:79–84.Search in Google Scholar

40. Mieda, M. The central circadian clock of the suprachiasmatic nucleus as an ensemble of multiple oscillatory neurons. Neurosci Res 2020;156:24–31. https://doi.org/10.1016/j.neures.2019.08.003.Search in Google Scholar PubMed

Received: 2024-01-03
Accepted: 2024-02-27
Published Online: 2024-03-11
Published in Print: 2024-10-28

© 2024 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Circulating tumor DNA measurement: a new pillar of medical oncology?
  4. Reviews
  5. Circulating tumor DNA: current implementation issues and future challenges for clinical utility
  6. Circulating tumor DNA methylation: a promising clinical tool for cancer diagnosis and management
  7. Opinion Papers
  8. The final part of the CRESS trilogy – how to evaluate the quality of stability studies
  9. The impact of physiological variations on personalized reference intervals and decision limits: an in-depth analysis
  10. Computational pathology: an evolving concept
  11. Perspectives
  12. Dynamic mirroring: unveiling the role of digital twins, artificial intelligence and synthetic data for personalized medicine in laboratory medicine
  13. General Clinical Chemistry and Laboratory Medicine
  14. Macroprolactin in mothers and their babies: what is its origin?
  15. The influence of undetected hemolysis on POCT potassium results in the emergency department
  16. Quality control in the Netherlands; todays practices and starting points for guidance and future research
  17. QC Constellation: a cutting-edge solution for risk and patient-based quality control in clinical laboratories
  18. OILVEQ: an Italian external quality control scheme for cannabinoids analysis in galenic preparations of cannabis oil
  19. Using Bland-Altman plot-based harmonization algorithm to optimize the harmonization for immunoassays
  20. Comparison of a two-step Tempus600 hub solution single-tube vs. container-based, one-step pneumatic transport system
  21. Evaluating the HYDRASHIFT 2/4 Daratumumab assay: a powerful approach to assess treatment response in multiple myeloma
  22. Insight into the status of plasma renin and aldosterone measurement: findings from 526 clinical laboratories in China
  23. Reference Values and Biological Variations
  24. Reference values for plasma and urine trace elements in a Swiss population-based cohort
  25. Stimulating thyrotropin receptor antibodies in early pregnancy
  26. Within- and between-subject biological variation estimates for the enumeration of lymphocyte deep immunophenotyping and monocyte subsets
  27. Diurnal and day-to-day biological variation of salivary cortisol and cortisone
  28. Web-accessible critical limits and critical values for urgent clinician notification
  29. Cancer Diagnostics
  30. Thyroglobulin measurement is the most powerful outcome predictor in differentiated thyroid cancer: a decision tree analysis in a European multicenter series
  31. Cardiovascular Diseases
  32. Interaction of heparin with human cardiac troponin complex and its influence on the immunodetection of troponins in human blood samples
  33. Diagnostic performance of a point of care high-sensitivity cardiac troponin I assay and single measurement evaluation to rule out and rule in acute coronary syndrome
  34. Corrigendum
  35. Reference intervals of 24 trace elements in blood, plasma and erythrocytes for the Slovenian adult population
  36. Letters to the Editor
  37. Disturbances of calcium, magnesium, and phosphate homeostasis: incidence, probable causes, and outcome
  38. Validation of the enhanced liver fibrosis (ELF)-test in heparinized and EDTA plasma for use in reflex testing algorithms for metabolic dysfunction-associated steatotic liver disease (MASLD)
  39. Detection of urinary foam cells diagnosing the XGP with thrombopenia preoperatively: a case report
  40. Methemoglobinemia after sodium nitrite poisoning: what blood gas analysis tells us (and what it might not)
  41. Novel thiopurine S-methyltransferase (TPMT) variant identified in Malay individuals
  42. Congress Abstracts
  43. 56th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC – Laboratory Medicine)
Downloaded on 7.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2024-0009/html
Scroll to top button